These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 21247314

  • 1. Nucleic acid testing to detect HBV infection in blood donors.
    Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W.
    N Engl J Med; 2011 Jan 20; 364(3):236-47. PubMed ID: 21247314
    [Abstract] [Full Text] [Related]

  • 2. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group.
    Transfusion; 2004 Sep 20; 44(9):1332-9. PubMed ID: 15318857
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
    Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA.
    Transfusion; 2005 Aug 20; 45(8):1247-57. PubMed ID: 16078909
    [Abstract] [Full Text] [Related]

  • 4. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP.
    Transfus Clin Biol; 2004 Feb 20; 11(1):26-32. PubMed ID: 14980546
    [Abstract] [Full Text] [Related]

  • 5. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research GroupJapanese Red Cross Plasma Fractionation Center, Tokyo 105-0013, Japan..
    Jpn J Infect Dis; 2000 Jun 20; 53(3):116-23. PubMed ID: 10957709
    [Abstract] [Full Text] [Related]

  • 6. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR.
    Transfus Apher Sci; 2009 Aug 20; 41(1):3-7. PubMed ID: 19487161
    [Abstract] [Full Text] [Related]

  • 7. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM, Chudy M, Volkers P, Löwer J.
    Transfusion; 2006 Nov 20; 46(11):1886-91. PubMed ID: 17076842
    [Abstract] [Full Text] [Related]

  • 8. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA, Stramer SL, Kuhns MC, Schlauder GG.
    Transfusion; 2012 Oct 20; 52(10):2201-8. PubMed ID: 22321072
    [Abstract] [Full Text] [Related]

  • 9. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.
    Transfusion; 2012 Feb 20; 52(2):440-6. PubMed ID: 21810101
    [Abstract] [Full Text] [Related]

  • 10. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan 20; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 11. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.
    Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G.
    Transfusion; 2007 Oct 20; 47(10):1794-802. PubMed ID: 17880603
    [Abstract] [Full Text] [Related]

  • 12. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.
    Transpl Infect Dis; 2008 Dec 20; 10(6):391-5. PubMed ID: 18665905
    [Abstract] [Full Text] [Related]

  • 13. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
    Panhotra BR, Bahrani A, Joshi CS, ul Hassan Z.
    J Infect; 2005 Oct 20; 51(3):263. PubMed ID: 16125778
    [No Abstract] [Full Text] [Related]

  • 14. Hepatitis B virus blood screening: unfinished agendas.
    Comanor L, Holland P.
    Vox Sang; 2006 Jul 20; 91(1):1-12. PubMed ID: 16756595
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP.
    Vox Sang; 2004 Feb 20; 86(2):83-91. PubMed ID: 15023176
    [Abstract] [Full Text] [Related]

  • 19. Molecular characterization of occult hepatitis B cases in Greek blood donors.
    Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A.
    J Med Virol; 2009 May 20; 81(5):815-25. PubMed ID: 19319945
    [Abstract] [Full Text] [Related]

  • 20. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
    Gutiérrez C, Devesa M, Loureiro CL, León G, Liprandi F, Pujol FH.
    J Med Virol; 2004 Jun 20; 73(2):200-7. PubMed ID: 15122793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.